Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| interneuron | 6 studies | 28% ± 21% | |
| GABAergic neuron | 5 studies | 40% ± 16% | |
| pericyte | 4 studies | 42% ± 29% | |
| glutamatergic neuron | 4 studies | 28% ± 11% | |
| granule cell | 3 studies | 28% ± 11% | |
| retinal rod cell | 3 studies | 66% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| thymus | 100% | 759.15 | 650 / 653 | 36% | 1.23 | 219 / 605 |
| kidney | 70% | 220.20 | 62 / 89 | 40% | 1.85 | 357 / 901 |
| breast | 98% | 718.72 | 449 / 459 | 8% | 0.26 | 86 / 1118 |
| ovary | 73% | 143.30 | 131 / 180 | 29% | 1.20 | 124 / 430 |
| adipose | 100% | 1326.48 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| uterus | 75% | 171.44 | 127 / 170 | 19% | 2.50 | 87 / 459 |
| skin | 41% | 76.31 | 748 / 1809 | 40% | 2.67 | 188 / 472 |
| bladder | 71% | 146.52 | 15 / 21 | 4% | 0.47 | 22 / 504 |
| brain | 37% | 129.12 | 985 / 2642 | 27% | 0.85 | 191 / 705 |
| esophagus | 50% | 101.20 | 726 / 1445 | 3% | 0.13 | 6 / 183 |
| blood vessel | 51% | 109.45 | 683 / 1335 | 0% | 0 | 0 / 0 |
| liver | 38% | 65.89 | 86 / 226 | 1% | 0.03 | 5 / 406 |
| prostate | 25% | 42.01 | 61 / 245 | 11% | 0.28 | 56 / 502 |
| muscle | 36% | 121.93 | 287 / 803 | 0% | 0 | 0 / 0 |
| intestine | 31% | 54.73 | 303 / 966 | 1% | 0.02 | 4 / 527 |
| lung | 19% | 35.80 | 112 / 578 | 13% | 1.88 | 146 / 1155 |
| stomach | 23% | 36.57 | 84 / 359 | 2% | 0.06 | 7 / 286 |
| adrenal gland | 10% | 13.77 | 25 / 258 | 9% | 0.22 | 21 / 230 |
| heart | 16% | 25.23 | 136 / 861 | 0% | 0 | 0 / 0 |
| spleen | 8% | 13.69 | 19 / 241 | 0% | 0 | 0 / 0 |
| pancreas | 2% | 2.97 | 8 / 328 | 4% | 0.15 | 8 / 178 |
| eye | 0% | 0 | 0 / 0 | 3% | 0.03 | 2 / 80 |
| tonsil | 0% | 0 | 0 / 0 | 2% | 0.05 | 1 / 45 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0005615 | Cellular component | extracellular space |
| GO_0005788 | Cellular component | endoplasmic reticulum lumen |
| GO_0005581 | Cellular component | collagen trimer |
| GO_0005576 | Cellular component | extracellular region |
| GO_0062023 | Cellular component | collagen-containing extracellular matrix |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0016020 | Cellular component | membrane |
| GO_0008201 | Molecular function | heparin binding |
| GO_0030020 | Molecular function | extracellular matrix structural constituent conferring tensile strength |
| GO_0001540 | Molecular function | amyloid-beta binding |
| Gene name | COL25A1 |
| Protein name | COL25A1 protein Collagen type XXV alpha 1 chain Uncharacterized protein COL25A1 Collagen alpha-1(XXV) chain (Alzheimer disease amyloid-associated protein) (AMY) (CLAC-P) [Cleaved into: Collagen-like Alzheimer amyloid plaque component (CLAC)] |
| Synonyms | |
| Description | FUNCTION: Inhibits fibrillization of amyloid-beta peptide during the elongation phase. Has also been shown to assemble amyloid fibrils into protease-resistant aggregates. Binds heparin. . |
| Accessions | ENST00000399132.6 [Q9BXS0-1] ENST00000512961.5 A0A2R8Y760 D6R8Y2 ENST00000399126.1 [Q9BXS0-2] ENST00000642955.1 ENST00000494183.5 ENST00000505591.1 E9PNV9 H0YAE1 Q9BXS0 ENST00000399127.5 Q4W5I4 Q8NE08 A8MWQ5 |
